---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-023257"
form_type: "8-K"
ticker: "JANX"
cik: "0001817713"
company_name: "Janux Therapeutics, Inc."
filed_at: "2024-02-29T23:59:59+00:00"
generated_at: "2026-06-05T07:14:02.697769+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Janux Therapeutics prices $296.5M public offering of common stock and pre-funded warrants

## Summary
- Pricing: 4,440,851 shares at $46.50/share and pre-funded warrants to purchase 1,935,483 shares at $46.499.
- Gross proceeds ~$296.5M, up from initial $175M offering; underwriters have 30-day option for 956,450 shares.
- Proceeds to fund clinical pipeline development and general corporate purposes; close expected March 4, 2024.

## SEC filing metadata
- accession: 0000950170-24-023257
- form_type: 8-K
- ticker: JANX
- cik: 0001817713
- company_name: Janux Therapeutics, Inc.
- filed_at: 2024-02-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1817713/000095017024023257/0000950170-24-023257-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1817713/000095017024023257/janx-20240228.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-023257
- JSON: https://secwatch.observer/filing/0000950170-24-023257.json
- Plain text: https://secwatch.observer/filing/0000950170-24-023257.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.